National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 5,295 cases where Vaccine is COVID19 and Manufacturer is MODERNA and Symptom is Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coagulopathy or Deep vein thrombosis or Disseminated intravascular coagulation or Embolism or Idiopathic thrombocytopenic purpura or Immune thrombocytopenia or Immune thrombocytopenic purpura or Ischaemic stroke or Myocardial infarction or Petechiae or Pulmonary embolism or Purpura or Thrombocytopenia or Thrombosis or Vasculitis



Case Details

This is page 13 out of 530

Result pages: prev   4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22   next


VAERS ID: 998022 (history)  
Form: Version 2.0  
Age: 77.0  
Sex: Female  
Location: California  
Vaccinated:2021-01-26
Onset:2021-01-28
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Angiogram pulmonary abnormal, Deep vein thrombosis, Peripheral swelling, Pulmonary embolism
SMQs:, Cardiac failure (broad), Angioedema (broad), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Pulmonary hypertension (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Metastatic ovarian cancer Metastatic head and neck cancer
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Left deltoid IM injection on 1/26/21 Left upper extremity swelling on 1/28/21 Presented to clinic on 2/2/21 and was found to have an acute LUE DVT and an acute PE on CTA chest


VAERS ID: 998544 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Male  
Location: Kentucky  
Vaccinated:2021-01-13
Onset:2021-01-25
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 013L20A / 1 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-25
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Multiple medication
Current Illness: diabetes, heart trouble, dementia
Preexisting Conditions: as above
Allergies: Morphine and iodine
Diagnostic Lab Data: Stents placed.
CDC Split Type:

Write-up: Patient had heart attack. Spoke with spouse on 2/3/2021 stated had multiple health issues including heart and lung issues.


VAERS ID: 998832 (history)  
Form: Version 2.0  
Age: 27.0  
Sex: Female  
Location: Ohio  
Vaccinated:2021-01-13
Onset:2021-01-14
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 013L20A / 1 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Blood test, Chest pain, Dyspnoea, Pulmonary embolism
SMQs:, Anaphylactic reaction (broad), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Prenatal vitamins
Current Illness:
Preexisting Conditions:
Allergies: Chocolate Cinnamon Glycerin Vicodin Amoxicillin Cefzil Flagyl
Diagnostic Lab Data: Ddimer
CDC Split Type:

Write-up: Shortness of breath and severe Chest pain. Ended up being a pulmonary embolism. Placed on Eliquis.


VAERS ID: 998919 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Female  
Location: New York  
Vaccinated:2021-01-13
Onset:2021-01-14
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 011520A / 1 LA / SYR
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 0115J0A / 1 LA / SYR

Administered by: Military       Purchased by: ?
Symptoms: Contusion, Petechiae, Purpura, Skin haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Accidents and injuries (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Lamictal Adderall Ativan Aripiprazole Prilosec Nicotinamide Multivitamin Lamictal Adderall XR Ativan Aripiprazole Prilosec Iron and Vitamin C Nicotinamide Iron plus Vitamin C
Current Illness: None
Preexisting Conditions: had Vertical Sleeve Gastrectomy in 2018
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: 9am (jan 14th) noticed bleeding under skin: 2 dark purple dark red areas (1.5" diameter and 2" diameter) on front of left hand. No pain /itching. Had no physical activity that day or the day before after. I noticed them because they looked like severe bruising or burn symptoms but had no pain in the areas. They were very noticeable and my bruises always hurt. These did not. Saw a telehealth provider and was told it was purpura / petechiae. I''m not sure about the lot number because the Covid-19 Vaccination card is almost illegible. It is definitely Moderna and the lot number is definitely "011_ _0A". The first unknown digit is either 5 or S and the second unknown is J or 2. Site number is hard to see. THERE IS NO HOSPITAL OR CLINIC ON THIS ISLAND. SHOULD I GET THE SECOND DOSE HERE? I am pro-vaccines but am afraid to get second dose if the first dose is related to a blood clotting reaction.


VAERS ID: 1001117 (history)  
Form: Version 2.0  
Age: 24.0  
Sex: Female  
Location: Ohio  
Vaccinated:2021-01-14
Onset:2021-01-15
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 012L20A / 1 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Urticaria, Vasculitis
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Vasculitis (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Oral contraceptive
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: Blood work and follow up with PCP to be completed at a later date.
CDC Split Type:

Write-up: Scattered areas of urticaria (hives) spreading diffusely over body. Some areas of vasculitis on arms and legs. Symptoms began within 24 hours of vaccine and have continued until present date. Prednisone prescription given on February 18th and taken for 9 days as prescribed (20MG- 3 tabs x 3 days, 2 tabs x 3 days, 1 tab x 3 days) taken with Benadryl as advised. Symptoms continued. Urgent care visit on February 3rd. Treated with methylPREDNISolone sod suc(PF) (SOLU-medrol) Injection 125 mg and prescribed predniSONE (DELTASONE) 20 MG tablet and famotidine (PEPCID) 40 MG tablet. Following injection skin is moderately less irritated.


VAERS ID: 1002599 (history)  
Form: Version 2.0  
Age: 54.0  
Sex: Female  
Location: Virginia  
Vaccinated:2021-01-15
Onset:2021-01-17
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 012L20A / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Purpura
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Xarelto, Nortryptyline, MVI
Current Illness: none
Preexisting Conditions: Fibromyalgia, Hx DVT times 2
Allergies: no
Diagnostic Lab Data: none
CDC Split Type:

Write-up: Developed "blood spots" on legs that progressed. Went to see MD, no specific treatment, employee recovered after 10 days


VAERS ID: 1003188 (history)  
Form: Version 2.0  
Age: 25.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2021-01-29
Onset:2021-01-30
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 012M20A / 2 LA / IM

Administered by: Work       Purchased by: ?
Symptoms: Eye swelling, Fatigue, Lip swelling, Petechiae, Rash, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Kyleena IUD Vitamin D Fish Oil
Current Illness: none
Preexisting Conditions: Anxiety
Allergies: none
Diagnostic Lab Data: No testing performed
CDC Split Type:

Write-up: Urticarial rash over whole body including face, moderate swelling of lips eyes beginning 8pm 1/30/21. Rash most concentrated over trunk and thighs, center of face around nose. Worsened overnight (1/30/21-1/31/21)despite use of benadryl 2 tablets (50mg) night prior and every 4-6 hours following. care provider seen 1/31/21 9AM, prescribed prednisone (first dose 11AM) and advised continuing benadryl 2 tablets 4-6 hours. Prednisone 10mg TID x 3 days, 10mg bid x 3 days, 10mg qd x 3 days. Continued Benadryl every 4 hours. Rash on body and face peaked 1/31/21 3pm, mild improvement overnight to 2/1/21. 2/1//21: Rash increased in intensity on distal LEs (feet/ankles) and UEs (wrists). Appearance of petichiae on trunk, lateral thighs. 2/2/21: Rash improving, fatigue. 2/3/21: rash nearly resolved, petichiae remain 2/4/21: Rash resolved petichiae improving.


VAERS ID: 1003445 (history)  
Form: Version 2.0  
Age: 77.0  
Sex: Female  
Location: New York  
Vaccinated:2021-02-04
Onset:2021-02-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 030M20A / 1 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Coagulopathy, Injection site bruising, Injection site haemorrhage, Injection site swelling
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: diabetic
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Administered vaccine into patient left deltoid, patient began to bleed and not clot quickly. Patient was dripping blood from vaccine site for 2 minutes, EMS was called in to confirm patient was feeling well and not pass out. Patient began to bruise and swell at injection site. Patient was coherent entire time, able to walk and move and stay for monitoring for 30 minutes. Patient denied medical transport.


VAERS ID: 1011163 (history)  
Form: Version 2.0  
Age: 51.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-01-04
Onset:2021-01-05
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 039K20A / 1 UN / IM

Administered by: Other       Purchased by: ?
Symptoms: Coagulopathy, Haematuria
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Tubulointerstitial diseases (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: hematuria Narrative: Employee stated that she had hematuria with clots the morning after her vaccination, It was recommended that she see her private physician


VAERS ID: 1004204 (history)  
Form: Version 2.0  
Age: 72.0  
Sex: Female  
Location: New York  
Vaccinated:2021-01-18
Onset:2021-01-19
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 LA / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Platelet count decreased, Platelet transfusion, Thrombocytopenia
SMQs:, Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event (No medical history reported)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: Thrombocytopenia/lowplatelet; A spontaneous report was received from a caregiver concerning a 72-year-old, female patient who received Moderna''s COVID-19 vaccine (mRNA-1273) and experienced thrombocytopenia/low platelet count. The patient''s medical history was not provided. No relevant concomitant medications were reported. On 18 Jan 2021 at 04:00 pm, approximately one day prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 19 Jan 2021, the patient was hospitalized for thrombocytopenia/low platelet count, the patient was in emergency room and was given a strong dose of steroid. Her body did not react to it and she was then given a platelet transfusion. The doctors have given her steroids, immunoglobulin and aminocaproic acid during the hospitalization. They were discussing the next steps of therapy and plan to try rituximab. Action taken with mRNA-1273 in response to the event was not reported. The outcome of the event thrombocytopenia/low platelet count was unknown.; Reporter''s Comments: This case concerns a 72-year-old, female patient, who experienced a serious unexpected event of thrombocytopenia. This event occurred 2 days after first dose of mRNA-1273, lot # unknown. Treatment included steroids, platelet transfusion, immunoglobulin, Amicar and pending treatment with Rituximab. Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded.


Result pages: prev   4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=13&SYMPTOMS[]=Cerebral_venous_sinus_thrombosis_%2810083037%29&SYMPTOMS[]=Cerebral_venous_thrombosis_%2810008138%29&SYMPTOMS[]=Coagulopathy_%2810009802%29&SYMPTOMS[]=Deep_vein_thrombosis_%2810051055%29&SYMPTOMS[]=Disseminated_intravascular_coagulation_%2810013442%29&SYMPTOMS[]=Embolism_%2810061169%29&SYMPTOMS[]=Idiopathic_thrombocytopenic_purpura_%2810021245%29&SYMPTOMS[]=Immune_thrombocytopenia_%2810083842%29&SYMPTOMS[]=Immune_thrombocytopenic_purpura_%2810074667%29&SYMPTOMS[]=Ischaemic_stroke_%2810061256%29&SYMPTOMS[]=Myocardial_infarction_%2810028596%29&SYMPTOMS[]=Petechiae_%2810034754%29&SYMPTOMS[]=Pulmonary_embolism_%2810037377%29&SYMPTOMS[]=Purpura_%2810037549%29&SYMPTOMS[]=Thrombocytopenia_%2810043554%29&SYMPTOMS[]=Thrombosis_%2810043607%29&SYMPTOMS[]=Vasculitis_%2810047115%29&VAX=COVID19&VAXMAN=MODERNA

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166